Treatment

Buloxibutid clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
This study, called ASPIRE, is testing a new medication, Buloxibutid, for Idiopathic Pulmonary Fibrosis (IPF). It compares the new drug to a dummy pill (placebo) to see if it's safe and helps improve lung function over 52 weeks.
For: Idiopathic Pulmonary Fibrosis (IPF)
United States · Argentina · Australia